PortfoliosLab logoPortfoliosLab logo
VERU vs. NVAX
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

VERU vs. NVAX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Veru Inc. (VERU) and Novavax, Inc. (NVAX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, VERU achieves a 42.06% return, which is significantly higher than NVAX's 33.93% return. Over the past 10 years, VERU has outperformed NVAX with an annualized return of -13.72%, while NVAX has yielded a comparatively lower -23.62% annualized return.


VERU

1D
2.70%
1M
29.36%
YTD
42.06%
6M
31.03%
1Y
-50.97%
3Y*
-35.44%
5Y*
-48.29%
10Y*
-13.72%

NVAX

1D
0.00%
1M
-2.28%
YTD
33.93%
6M
32.35%
1Y
42.63%
3Y*
10.34%
5Y*
-45.80%
10Y*
-23.62%
*Multi-year figures are annualized to reflect compound growth (CAGR)

VERU vs. NVAX - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
VERU
Veru Inc.
42.06%-67.10%-9.65%-86.36%-10.36%-31.91%158.21%139.29%22.81%25.27%
NVAX
Novavax, Inc.
33.93%-16.42%67.50%-53.31%-92.81%28.30%2,701.76%-89.18%48.39%-1.59%

Correlation

The correlation between VERU and NVAX is 0.34, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.34

Correlation (3Y)
Calculated over the trailing 3-year period

0.24

Correlation (5Y)
Calculated over the trailing 5-year period

0.28

Correlation (10Y)
Calculated over the trailing 10-year period

0.22

Correlation (All Time)
Calculated using the full available price history since Feb 11, 1999

0.15

The correlation between VERU and NVAX shifts across timeframes, from 0.15 (all time) to 0.34 (1 year), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

VERU:

$65.83M

NVAX:

$1.47B

EPS

VERU:

-$0.78

NVAX:

-$0.52

PS Ratio

VERU:

178.51

NVAX:

2.55

Total Revenue (TTM)

VERU:

$303.45K

NVAX:

$596.34M

Gross Profit (TTM)

VERU:

-$57.90K

NVAX:

$504.72M

EBITDA (TTM)

VERU:

-$8.20M

NVAX:

-$57.01M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Veru Inc.

Novavax, Inc.

Return for Risk

VERU vs. NVAX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

VERU
VERU Risk / Return Rank: 2222
Overall Rank
VERU Sharpe Ratio Rank: 2323
Sharpe Ratio Rank
VERU Sortino Ratio Rank: 2323
Sortino Ratio Rank
VERU Omega Ratio Rank: 2424
Omega Ratio Rank
VERU Calmar Ratio Rank: 1515
Calmar Ratio Rank
VERU Martin Ratio Rank: 2424
Martin Ratio Rank

NVAX
NVAX Risk / Return Rank: 6464
Overall Rank
NVAX Sharpe Ratio Rank: 6363
Sharpe Ratio Rank
NVAX Sortino Ratio Rank: 6666
Sortino Ratio Rank
NVAX Omega Ratio Rank: 6262
Omega Ratio Rank
NVAX Calmar Ratio Rank: 6565
Calmar Ratio Rank
NVAX Martin Ratio Rank: 6464
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

VERU vs. NVAX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Veru Inc. (VERU) and Novavax, Inc. (NVAX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


VERUNVAXDifference
Sharpe ratioReturn per unit of total volatility

-1.08

Sortino ratioReturn per unit of downside risk

-1.81

Omega ratioGain probability vs. loss probability

0.96

1.16

-0.21

Calmar ratioReturn relative to maximum drawdown

-0.73

1.19

-1.92

Martin ratioReturn relative to average drawdown

-0.90

2.30

-3.19

VERU vs. NVAX - Sharpe Ratio Comparison

The current VERU Sharpe Ratio is -0.45, which is lower than the NVAX Sharpe Ratio of 0.62. The chart below compares the historical Sharpe Ratios of VERU and NVAX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

VERU vs. NVAX - Drawdown Comparison

The maximum VERU drawdown since its inception was -99.12%, roughly equal to the maximum NVAX drawdown of -98.82%. Use the drawdown chart below to compare losses from any high point for VERU and NVAX.


Loading charts...

Drawdown Indicators


VERUNVAXDifference

Max Drawdown

Largest peak-to-trough decline

-99.12%

-98.82%

-0.30%

Max Drawdown (1Y)

Largest decline over 1 year

-69.93%

-35.94%

-33.99%

Max Drawdown (3Y)

Largest decline over 3 years

-88.32%

-74.11%

-14.21%

Max Drawdown (5Y)

Largest decline over 5 years

-99.12%

-98.61%

-0.51%

Max Drawdown (10Y)

Largest decline over 10 years

-99.12%

-98.82%

-0.30%

Current Drawdown

Current decline from peak

-98.72%

-97.19%

-1.53%

Average Drawdown

Average peak-to-trough decline

-54.11%

-70.78%

+16.67%

Ulcer Index

Depth and duration of drawdowns from previous peaks

56.95%

18.59%

+38.36%

Volatility

VERU vs. NVAX - Volatility Comparison

Veru Inc. (VERU) has a higher volatility of 71.62% compared to Novavax, Inc. (NVAX) at 23.73%. This indicates that VERU's price experiences larger fluctuations and is considered to be riskier than NVAX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


VERUNVAXDifference

Volatility (1M)

Calculated over the trailing 1-month period

71.62%

23.73%

+47.89%

Volatility (6M)

Calculated over the trailing 6-month period

78.08%

52.56%

+25.52%

Volatility (1Y)

Calculated over the trailing 1-year period

113.11%

68.58%

+44.53%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

137.04%

105.98%

+31.06%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

112.82%

115.57%

-2.75%

Dividends

VERU vs. NVAX - Dividend Comparison

Neither VERU nor NVAX has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

VERU vs. NVAX - Financials Comparison

This section allows you to compare key financial metrics between Veru Inc. and Novavax, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


-500.00M0.00500.00M20222023202420252026
56.39K
139.51M
(VERU) Total Revenue
(NVAX) Total Revenue
Values in USD except per share items

Frequently Asked Questions


VERU and NVAX have a correlation of 0.34, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

VERU has higher volatility (71.62%) compared to NVAX (23.73%). In terms of maximum drawdown, VERU dropped -99.12% vs NVAX's -98.82%.

NVAX currently has the higher Sharpe Ratio (0.62 vs -0.45), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for VERU and NVAX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer